Robert F Gagel
Affiliations: | MD Anderson Cancer Center, Houston, TX, United States |
Area:
Bone Biology, Endocrine NeoplasiaGoogle:
"Robert Gagel"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Armen H. Tashjian | post-doc | 1977-1981 | Harvard Medical School | |
| (Four year post-doctoral fellowship at Harvard School of Dental Medicine and Harvard School of Public Health) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Grubbs EG, Halperin DM, Waguespack SG, et al. (2020) History of the multiple endocrine neoplasia workshops and overview of MEN2019. Endocrine-Related Cancer |
| Sinha KM, Bagheri-Yarmand R, Lahiri S, et al. (2019) Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene |
| Bagheri-Yarmand R, Li L, Tarapore R, et al. (2019) Abstract 1286: ONC201 inhibits RET and IGFBP2 signaling through ATF4 mediated- Integrated stress response in medullary thyroid cancer Cancer Research. 79: 1286-1286 |
| Bagheri-Yarmand R, Sinha KM, Li L, et al. (2018) Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. Molecular Cancer Research : McR |
| Romero Arenas MA, Rich TA, Hyde SM, et al. (2018) Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Annals of Surgical Oncology |
| Bagheri-Yarmand R, Sinha KM, Li L, et al. (2018) Abstract 2426: Tyrosine kinase and ERAD inhibitors promote oxidative stress-induced apoptosis through activation of ATF4 / KLF9 axis in medullary thyroid cancer Cancer Research. 78: 2426-2426 |
| Voss RK, Feng L, Lee JE, et al. (2017) Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness The Journal of Clinical Endocrinology and Metabolism |
| Bagheri-Yarmand R, Sinha K, Lu Y, et al. (2017) Abstract LB-112: Tyrosine kinase and ERAD inhibitors synergize to promote apoptosis through ATF4 induction in medullary thyroid cancer Cancer Research. 77 |
| Bagheri-Yarmand R, Williams MD, Grubbs EG, et al. (2016) ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism. jc20162878 |
| Long KL, Etzel C, Rich T, et al. (2016) All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Familial Cancer |